Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)LeasesOther Gross PP&E AdjustmentsReceivables - Other
Ratios

Moleculin Biotech (MBRX) Accumulated Depreciation & Amortization (2016 - 2019)

Moleculin Biotech's Accumulated Depreciation & Amortization history spans 4 years, with the latest figure at $199000.0 for Q4 2019.

  • Quarterly results put Accumulated Depreciation & Amortization at $199000.0 for Q4 2019, up 192.65% from a year ago — trailing twelve months through Dec 2019 was $199000.0 (up 192.65% YoY), and the annual figure for FY2019 was $199000.0, up 192.65%.
  • Accumulated Depreciation & Amortization for Q4 2019 was $199000.0 at Moleculin Biotech, up from $68000.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $199000.0 in Q4 2019 to a low of $1000.0 in Q2 2016.
  • The 4-year median for Accumulated Depreciation & Amortization is $7500.0 (2018), against an average of $28416.7.
  • The sharpest move saw Accumulated Depreciation & Amortization skyrocketed 1200.0% in 2017, then fell 15.38% in 2018.
  • Year by year, Accumulated Depreciation & Amortization stood at $6000.0 in 2016, then soared by 200.0% to $18000.0 in 2017, then skyrocketed by 277.78% to $68000.0 in 2018, then skyrocketed by 192.65% to $199000.0 in 2019.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $199000.0, $68000.0, and $11000.0 for Q4 2019, Q4 2018, and Q3 2018 respectively.